Abstract
The influence of age and gender on the pharmacokinetics of levofloxacin in healthy subjects receiving a single oral 500-mg dose of levofloxacin was investigated in this parallel design study. Six young males (aged 18 to 40 years), six elderly males (aged > or = 65 years), six young females (aged 18 to 40 years), and six elderly females (aged > or = 65 years) were enrolled and completed the study. The study reveals that the bioavailability (rate and extent) of levofloxacin was not affected by either age or gender. In both age (young and elderly) and gender (male and female) groups of subjects, peak concentrations in plasma were reached at approximately 1.5 h after dosing; renal clearance of levofloxacin accounted for approximately 77% of total body clearance, and approximately 76% of the administered dose was recovered unchanged in urine over the 36 h of collection. The apparent differences in the calculated pharmacokinetic parameters for levofloxacin between the age groups (young versus elderly) and between the gender groups (males versus females) could be explained by differences in renal function among the subjects. A single dose of 500 mg of levofloxacin administered orally to both young and old, male and female healthy subjects was found to be safe and well tolerated. As the differences in levofloxacin kinetics between the young and the elderly or the males and the females are limited and are mainly related to the renal function of the subjects, dose adjustment based on age or gender alone is not necessary.
Full Text
The Full Text of this article is available as a PDF (139.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bertino J. S., Jr, Nafziger A. N. Pharmacokinetics of oral fleroxacin in male and premenopausal female volunteers. Antimicrob Agents Chemother. 1996 Mar;40(3):789–791. doi: 10.1128/aac.40.3.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41. doi: 10.1159/000180580. [DOI] [PubMed] [Google Scholar]
- Epstein M. Effects of aging on the kidney. Fed Proc. 1979 Feb;38(2):168–171. [PubMed] [Google Scholar]
- Greenblatt D. J., Sellers E. M., Shader R. I. Drug therapy: drug disposition in old age. N Engl J Med. 1982 May 6;306(18):1081–1088. doi: 10.1056/NEJM198205063061804. [DOI] [PubMed] [Google Scholar]
- Molinaro M., Villani P., Regazzi M. B., Rondanelli R., Doveri G. Pharmacokinetics of ofloxacin in elderly patients and in healthy young subjects. Eur J Clin Pharmacol. 1992;43(1):105–107. doi: 10.1007/BF02280765. [DOI] [PubMed] [Google Scholar]
- Okazaki O., Kojima C., Hakusui H., Nakashima M. Enantioselective disposition of ofloxacin in humans. Antimicrob Agents Chemother. 1991 Oct;35(10):2106–2109. doi: 10.1128/aac.35.10.2106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shah A., Lettieri J., Nix D., Wilton J., Heller A. H. Pharmacokinetics of high-dose intravenous ciprofloxacin in young and elderly and in male and female subjects. Antimicrob Agents Chemother. 1995 Apr;39(4):1003–1006. doi: 10.1128/aac.39.4.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yuen G. J. Altered pharmacokinetics in the elderly. Clin Geriatr Med. 1990 May;6(2):257–267. [PubMed] [Google Scholar]